[Killing effect of IL-12-activated A-NK cells on human hepatocellular carcinoma HepG-2 cells in vitro].
Wang
Zhi-Hua
ZH
Zhao
Dong-Lu
DL
Zhang
Chun-Yan
CY
D000818:Animals; D006528:Carcinoma, Hepatocellular / Q000098:blood supply / Q000473:pathology / Q000628:therapy; D045744:Cell Line, Tumor; D002478:Cells, Cultured; D003602:Cytotoxicity, Immunologic / Q000276:immunology; D005260:Female; D006801:Humans; D018664:Interleukin-12 / Q000494:pharmacology*; D007376:Interleukin-2 / Q000494:pharmacology; D007694:Killer Cells, Natural / Q000166:cytology / Q000187:drug effects / Q000276:immunology*; D008114:Liver Neoplasms, Experimental / Q000098:blood supply / Q000473:pathology / Q000628:therapy; D008213:Lymphocyte Activation / Q000187:drug effects* / Q000276:immunology; D008297:Male; D051379:Mice; D008807:Mice, Inbred BALB C; D008810:Mice, Inbred C57BL; D008833:Microcirculation / Q000187:drug effects; D011897:Random Allocation; D023041:Xenograft Model Antitumor Assays
D007376:Interleukin-2; D018664:Interleukin-12